PAVTIDE MDI 125/25 fluticasone propionate 125 mcg

Product details Supply Impact Dates Further Details
PAVTIDE MDI 125/25 fluticasone propionate 125 mcg

AUST R: 208670

Active Ingredients: fluticasone propionate~salmeterol xinafoate

Dosage From: Inhalation, pressurised
 From: 15 Sep 2025

To: 23 Sep 2025 		Shortage Status: Resolved

Availability: Available

Reason: Unexpected increase in consumer demand